Wound dressings play a critical role in wound management, yet engineering specialized solutions for biofilm-compromised chronic infections remains a formidable challenge. To address this, we developed a cellulase (Cel)-integrated hydrogel microneedle (MN) patch—comprising gallic acid (GA)-grafted oxidized konjac glucomannan (GA-OKGM), gelatin (Gel), and iron ions (denoted as Cel/Fe-GA-OKGM/Gel MNs)—for the programmed therapy and monitoring of chronic infected wounds. This hydrogel system features dual crosslinking via Fe-phenolic hydroxyl coordination bonds (GA-Fe) and Schiff base linkages (OKGM-Gel). By leveraging the physical penetration of MNs, surface-loaded cellulase efficiently degrades biofilms, thereby overcoming biofilm-mediated antimicrobial resistance. In vivo and in vitro studies demonstrate that these MNs exhibit potent biofilm-disrupting, antibacterial, anti-inflammatory, antioxidant, and macrophage-polarizing properties, collectively reprogramming the wound microenvironment to accelerate healing. Furthermore, the GA-Fe complex undergoes microenvironment-dependent chromatic transitions within wounds, serving as a real-time visual biomarker that dynamically reflects the progression of healing and infection status. This dual-functional “chameleon” system thus holds exceptional promise for the precise management of chronic infected wounds and future clinical translation.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: